HARROW, INC. — Director's Dealing 2017

May 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-04-27

Reporting Person: LINDSTROM RICHARD L MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-27	Common Stock	X	100000	$1.79	Acquired	100000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-27	Purchase Warrant	$1.79	G	100000	Disposed	2019-12-27	Common Stock (100000)	Direct
2017-04-27	Purchase Warrant	$1.79	G	100000	Acquired	2019-12-27	Common Stock (100000)	Indirect
2017-04-27	Purchase Warrant	$1.79	X	100000	Disposed	2019-12-27	Common Stock (100000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100000	Direct

Footnotes

F1: Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner.

F2: The non-exercisable period for the Purchase Warrant was waived by the Company in exchange for cash exercise, the original date the warrant became exercisable was June 27, 2017.